Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

Presentation TCT 2024

From Intervention to Prevention – The Best of Both Worlds or Just Too Complex?

Presenter: Marc Bonaca

October 29, 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

Presentation TCT 2022

Burnout and Prevention – Yes, this means you!

Presenter: Kim Guibone

September 16, 2022

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

News Conference News TCT 2020

Robotic PCI Can Protect Cath Lab Staff From COVID-19, Small Study Suggests

Todd Neale

October 22, 2020

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

Presentation TCT 2019

Your Cath Lab Needs a CIN Prevention Protocol: Here It Is!

Presenter: Hitinder Gurm

September 28, 2019

Presentation TCT 2019

How Could Advances in Digital Health Help in the Prevention of CV Diseases?: E-Prevention

Presenter: Mohammad El Tahlawi

September 28, 2019

Presentation TCT 2018

Advances in Digital Health May Help Prevent Cardiovascular Diseases: "E-Prevention"

Presenter: C. Michael Gibson, Mamas Mamas, Mohammad El Tahlawi

September 24, 2018

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

Presentation TCT 2014

No: Vorapaxar Is Effective, but Prasugrel and Ticagrelor are Preferred!

Presenter: Dirk Sibbing

September 14, 2014

Presentation TCT 2014

Yes: TRA-2P Has Proven it!

Presenter: David J. Moliterno

September 14, 2014

Presentation TCT 2014

NO: Cangrelor Is No Champion Next to the Appropriate Use of Potent Oral Antiplatelet Agents!

Presenter: Dimitrios Alexopoulos

September 14, 2014

Presentation TCT 2014

YES: CHAMPION PHOENIX was Convincing!

Presenter: Deepak L. Bhatt

September 14, 2014

Presentation TCT 2014

Yes: WOEST Definititely Proves Safety and Likely Efficacy as Well!

Presenter: Harvey D. White

September 14, 2014

Advertisement

From Intervention to Prevention – The Best of Both Worlds or Just Too Complex?

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

What’s Going to Be Big at TCT 2024?

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Burnout and Prevention – Yes, this means you!

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Robotic PCI Can Protect Cath Lab Staff From COVID-19, Small Study Suggests

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Your Cath Lab Needs a CIN Prevention Protocol: Here It Is!

How Could Advances in Digital Health Help in the Prevention of CV Diseases?: E-Prevention

Advances in Digital Health May Help Prevent Cardiovascular Diseases: "E-Prevention"

Discussion Highlights Merits, Limitations of Small Trials

No: Vorapaxar Is Effective, but Prasugrel and Ticagrelor are Preferred!

Yes: TRA-2P Has Proven it!

NO: Cangrelor Is No Champion Next to the Appropriate Use of Potent Oral Antiplatelet Agents!

YES: CHAMPION PHOENIX was Convincing!

Yes: WOEST Definititely Proves Safety and Likely Efficacy as Well!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content